Mometasone Teva (Mometasone Furoate)

Mometasone furoate binds to glucocorticoid receptors inside nasal mucosal cells. This binding modifies gene transcription, increasing anti‑inflammatory proteins and suppressing pro‑inflammatory cytokines, which reduces swelling, mucus production and immune cell activity in the nasal passages.

The exact dosing regimen is set by the prescribing healthcare professional. In typical practice, one spray per nostril once daily is common, but the prescriber may adjust frequency or duration based on the patient’s condition and response.

Safety data for mometasone furoate in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made together with a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs) and required import documentation.

Mometasone furoate is a high‑potency nasal corticosteroid with a low systemic absorption profile, similar to fluticasone propionate. Clinical studies suggest comparable efficacy in relieving allergic rhinitis symptoms, while the once‑daily dosing of mometasone may offer convenience for some patients.

Store the nasal spray at ambient temperature, ideally below 25 °C, in its original container. Protect it from moisture and direct sunlight. Do not freeze the product, and keep the cap tightly closed when not in use.

Mometasone Teva is delivered as a nasal spray. Before use, gently shake the bottle, prime it if required, and tilt the head slightly forward. Insert the tip into one nostril, close the opposite nostril, and spray while breathing in gently. Repeat in the other nostril as directed.

Serious adverse events, although rare, include adrenal suppression, cataracts or glaucoma, severe or persistent nosebleeds, opportunistic fungal infections of the nasal passages, and systemic hypersensitivity reactions such as anaphylaxis. Patients should seek medical attention if any of these occur.

Mometasone Teva should be avoided in individuals with known hypersensitivity to mometasone furoate or any excipients, and in patients with untreated bacterial, viral, or fungal nasal infections. Caution is also advised for those with uncontrolled glaucoma, cataracts, or a history of adrenal insufficiency.